{"url_path":"/sec/ctor/8-k/2026-05-15/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1851484/0001213900-26-057883-index.html","accession_number":"0001213900-26-057883","cik":"0001851484","ticker":"CTOR","issuer_name":"CITIUS ONCOLOGY, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1851484/0001213900-26-057883-index.html","primary_entity_key":"0001851484","primary_entity_name":"CITIUS ONCOLOGY, INC."},"word_count":82,"has_tables":true,"body_markdown":"**Item 9.01. Financial Statements and Exhibits.**\n\n \n\n(d) Exhibits\n\n \n\nExhibit No.\n \nDescription\n\n99.1\n \n[Press release, dated May 15, 2026.](ea029103501ex99-1.htm)\n\n104\n \nCover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL).\n\n \n\n1\n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n**CITIUS ONCOLOGY, INC.**\n\n \n \n\nDate: May 15, 2026\n/s/ Leonard Mazur\n\n \nLeonard Mazur\n\n \nChairman and Chief Executive Officer\n\n \n\n2"}